Education
About Us
Working with TipRanks
Follow Us
Abattis Bioceuticals Corp (ATTBF)
OTHER OTC:ATTBF
ATTBF Stock Chart & Stats
Day’s Range― - ―
52-Week Range<$0.01 - $0.01
Previous CloseN/A
Volume66.06K
Average Volume (3M)222.83K
Market Cap
$4.78K
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta95.80
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding477,804,140
10 Day Avg. Volume222,826
30 Day Avg. Volume222,826
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)0.00
Price to Sales (P/S)0.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
ATTBF FAQ
What was Abattis Bioceuticals Corp’s price range in the past 12 months?
Abattis Bioceuticals Corp lowest stock price was <$0.01 and its highest was $0.01 in the past 12 months.
What is Abattis Bioceuticals Corp’s market cap?
Abattis Bioceuticals Corp’s market cap is $4.78K.
When is Abattis Bioceuticals Corp’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Abattis Bioceuticals Corp’s earnings last quarter?
Currently, no data Available
Is Abattis Bioceuticals Corp overvalued?
According to Wall Street analysts Abattis Bioceuticals Corp’s price is currently Overvalued.
Does Abattis Bioceuticals Corp pay dividends?
Abattis Bioceuticals Corp does not currently pay dividends.
What is Abattis Bioceuticals Corp’s EPS estimate?
Abattis Bioceuticals Corp’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Abattis Bioceuticals Corp have?
Abattis Bioceuticals Corp has 477,804,140 shares outstanding.
What happened to Abattis Bioceuticals Corp’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Abattis Bioceuticals Corp?
Currently, no hedge funds are holding shares in ATTBF
Company Description
Abattis Bioceuticals Corp
Abattis Bioceuticals Corp. operates as a life sciences and biotechnology company in Canada. The company develops and licenses natural health products, medicines, extractions, and ingredients for the biological, nutraceutical, bioceutical, and cosmetic markets. It also provides Comfort, a cannabinoid enhanced nutraceutical for pain and inflammation; and Health-Canada licensed services for the cannabis industry. The company was formerly known as Abattis Biologix Corporation and changed its name to Abattis Bioceuticals Corporation in September 2012. Abattis Bioceuticals Corp. was incorporated in 1997 and is headquartered in Vancouver, Canada.
Abattis Bioceuticals (ATTBF) Earnings & Revenues
Currently, no data available
Please return soon. This page is being updated.
Technical Analysis
cbdMD
―
Cosmos Holdings
―
Flora Growth
―
Akanda Corp
―
Shuttle Pharmaceuticals Holdings, Inc.
―